tradmap

AEHR Financials Aehr Test Systems

15 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 24.7% per year over the past 5 years.
  • Operating margin has contracted, at -28.3% in the latest year.

Financial health

  • Total debt has grown slower than revenue (-22.4% vs 24.7% per year).
  • The company is unprofitable; at its current free-cash-flow burn it has roughly 21.6 years of cash runway.
Revenue & net income
-$7M $30M $66M $0 2012 2014 2016 2018 2020 2022 2024 2026
RevenueNet income
Margins (gross / operating / net)
-30% 10% 50% 0% 2012 2014 2016 2018 2020 2022 2024 2026
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-146% 410% 965% 0% 2012 2014 2016 2018 2020 2022 2024 2026
ROEROA
Free cash flow (CFO − capex)
-$12M -$2M $9M $0 2012 2014 2016 2018 2020 2022 2024 2026
Free cash flow
Cash vs total debt
$0 $58M $116M 2012 2014 2016 2018 2020 2022 2024 2026
CashTotal debt
Cash flow: operating / investing / financing
-$19M $39M $97M $0 2012 2014 2016 2018 2020 2022 2024 2026
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2026 $50M -$7M 35.3% -28.3% -3.2% -2.9% -$5M $116M
2025 $59M -$4M 40.6% -9.6% -3.2% -2.6% -$12M $25M
2024 $66M $33M 49.1% 15.2% 29.7% 25.9% $1M $49M
2023 $65M $15M 50.4% 20.6% 19.3% 14.8% $9M $30M
2022 $51M $9M 46.6% 15.3% 18.5% 15.2% $1M $31M
2021 $17M -$2M 36.3% -25.2% -17.7% -9.4% -$3M $2M $5M
2020 $22M -$3M 37.6% -12.4% -19.9% -13.6% -$2M $2M $5M
2019 $21M -$5M 36.1% -23.7% -33.8% -24.6% -$6M $0 $5M
2018 $30M $528000 41.9% 3.1% 2.7% 1.7% -$2M $0 $17M
2017 $19M -$6M 35.9% -26.1% -33.6% -18.3% -$5M $6M $18M
2016 -$7M 965.1% -67.5% -$7M $6M $939000
2015 -$7M -145.5% -44.7% -$2M $4M $6M
2014 $422000 6.0% 3.5% -$946000 $0 $2M
2013 -$3M -68.2% -31.2% -$437000 $2M
2012 -$3M -52.3% -29.2% -$5M $2M

Valuation over time

How the market has priced AEHR against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 58.5 117.0 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 31.3 62.7 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is AEHR growing its revenue and profit?

Over the past 5 years, Aehr Test Systems's revenue has grown 24.7% per year. These are computed facts, not advice.

How much debt does AEHR have?

As of FY2026, Aehr Test Systems reported — of total debt against $116M of cash.

What is AEHR's profit margin?

In FY2026, gross margin was 35.3%, operating margin -28.3%, and net margin -14.3%.

What is AEHR's P/E ratio?

As of Sep '26, Aehr Test Systems traded at a price-to-earnings ratio of about 8.4× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.